Wall Street analysts expect Amneal Pharmaceuticals (AMRX) to post quarterly earnings of $0.13 per share in its upcoming report, which indicates a year-over-year decline of 31.6%. Revenues are expected to be $693.68 million, up 11.9% from the year-ago quarter.The current level reflects a downward revision of 3.3% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.Be ...